Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency

MLA

Alessandro Petrucci, et al. “Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency.” Biology of Blood and Marrow Transplantation, vol. 16, no. 8, Aug. 2010, pp. 1115–21. EBSCOhost, https://doi.org/10.1016/j.bbmt.2010.02.020.

APA

Alessandro Petrucci, Michele Baccarani, Lucia Pantani, Patrizia Tosi, Michela Ceccolini, Michele Cavo, Annamaria Brioli, Elena Zamagni, Maria Caterina Pallotti, Giulia Perrone, & Paola Tacchetti. (2010). Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency. Biology of Blood and Marrow Transplantation, 16(8), 1115–1121. https://doi.org/10.1016/j.bbmt.2010.02.020

Chicago

Alessandro Petrucci, Michele Baccarani, Lucia Pantani, Patrizia Tosi, Michela Ceccolini, Michele Cavo, Annamaria Brioli, et al. 2010. “Thalidomide-Dexamethasone as Induction Therapy before Autologous Stem Cell Transplantation in Patients with Newly Diagnosed Multiple Myeloma and Renal Insufficiency.” Biology of Blood and Marrow Transplantation 16 (8): 1115–21. doi:10.1016/j.bbmt.2010.02.020.